# PetMed Express, Inc. (PETS) · Edgar & Edgarette company card

> PetMed Express (PETS) saw revenue fall 21.1% in FY2026 to $179 million, operating margin -32.8% against a 0.6% median for drug stores and proprietary stores, equity 35.6% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1040130 · fiscal year ended 2026-03-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/PETS) · [JSON](https://www.pops4.com/boards/company/PETS.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $179M |
| Revenue growth, 1 year | -21.1% |
| Revenue growth per year | -10.0% |
| Operating margin | -32.8% (prior year -0.7%) |
| Net margin | -32.0% |
| Operating cash flow | −$28M |
| Capital spending | $5M |
| Free cash flow | −$33M |
| Cash | $21M |
| Long-term debt | — |
| Total assets | $81M |
| Total equity | $29M |
| Equity ÷ assets | 35.6% |
| Return on equity | -197.9% |
| Dividend per share | $0 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Altman Z: -4.59 (distress zone)
- Piotroski F: 3 of 9 (middling)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed late quarterly report notice, auditor change in the last 12 months; slow and jumpy: growing slower than its size class, with revenue that swings more; operating cash flow was negative; operating loss: a margin of -32.8% in FY2026
- Cash Compass: Fading · slow and jumpy, lagging its peers

## Edgarette's reading

Exposure: revenue $179.0M (FY2026). Experience: revenue down 21.1% on the year, down 10.0% a year over 4 years; operating margin -32.8%, down from -0.7%. Soundness: equity 35.6% of assets, return on equity -197.9%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $120.8M and $179.2M next year (method v4.1: its own 5-year record of growth weighed at 57% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $109.4M to $198.8M. A statistical range, not company guidance. Against peers (57 filers, $50M+ revenue, its industry group): operating margin -32.8% against a 0.6% median; growth -21.1% against 4.1%.

Range logged 2026-09-24, receipt 67e4913d9e77e3d0, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2025-11-13 ([filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000086/0001040130-25-000086-index.htm))
- Item NT 10-Q Late quarterly report notice: 1, latest 2025-11-12 ([filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000083/0001040130-25-000083-index.htm))
- Item 4.01 Auditor change: 1, latest 2025-12-09 ([filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000097/0001040130-25-000097-index.htm))
- Item 5.02 Director or officer change: 6, latest 2026-09-28 ([filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013026000057/0001040130-26-000057-index.htm))

## Recent filings

- 8-K · filed 2026-09-28 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013026000057/0001040130-26-000057-index.htm)
- 8-K · filed 2026-09-21 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013026000047/0001040130-26-000047-index.htm)
- 8-K · filed 2026-09-17 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013026000045/0001040130-26-000045-index.htm)
- 10-Q · filed 2026-08-13 · [filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013026000041/0001040130-26-000041-index.htm)
- 8-K · filed 2026-08-13 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013026000040/0001040130-26-000040-index.htm)
- 8-K · filed 2026-08-12 · 5.02 Departure or Election of Directors; Appointment of Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013026000036/0001040130-26-000036-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001040130.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1040130

## Cite

POPS4, Edgar & Edgarette: PetMed Express, Inc. (PETS) company card, from the company's own SEC filings, accessed 2026-11-02, https://www.pops4.com/boards/company/PETS. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.